AMCP convened a diverse group of stakeholders for its Precision Medicine Partnership Forum to examine solutions that improve access, consistency, and quality in precision oncology. Attendees included patients, payers, pharmacy benefit managers, providers, pathologists, laboratory benefit managers, and leaders from advocacy organizations, coalitions, and professional associations. The multi-session event focused on aligning clinical guidelines, diagnostics, and managed care processes to ensure that innovation in cancer care leads to meaningful, equitable outcomes for patients.
Forum participants explored persistent challenges across the precision medicine access ecosystem , particularly in oncology. Experts pointed to fragmentation and misalignment as key contributors to care gaps, using the example of non-small cell lung cancer (NSCLC), and emphasized the need for system-level changes that better inform clinical decision making, reduce time to initiation with targeted therapies, and support guideline-concordant care.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
